1. Home
  2. TEF vs NTRA Comparison

TEF vs NTRA Comparison

Compare TEF & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEF
  • NTRA
  • Stock Information
  • Founded
  • TEF 1924
  • NTRA 2003
  • Country
  • TEF Spain
  • NTRA United States
  • Employees
  • TEF N/A
  • NTRA N/A
  • Industry
  • TEF Telecommunications Equipment
  • NTRA Medical Specialities
  • Sector
  • TEF Telecommunications
  • NTRA Health Care
  • Exchange
  • TEF Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • TEF 28.4B
  • NTRA 24.9B
  • IPO Year
  • TEF 1987
  • NTRA 2015
  • Fundamental
  • Price
  • TEF $5.27
  • NTRA $189.57
  • Analyst Decision
  • TEF
  • NTRA Strong Buy
  • Analyst Count
  • TEF 0
  • NTRA 17
  • Target Price
  • TEF N/A
  • NTRA $196.24
  • AVG Volume (30 Days)
  • TEF 497.3K
  • NTRA 1.1M
  • Earning Date
  • TEF 11-04-2025
  • NTRA 11-07-2025
  • Dividend Yield
  • TEF 4.47%
  • NTRA N/A
  • EPS Growth
  • TEF N/A
  • NTRA N/A
  • EPS
  • TEF N/A
  • NTRA N/A
  • Revenue
  • TEF $48,779,800,354.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • TEF N/A
  • NTRA $24.17
  • Revenue Next Year
  • TEF $0.44
  • NTRA $15.57
  • P/E Ratio
  • TEF N/A
  • NTRA N/A
  • Revenue Growth
  • TEF 3.10
  • NTRA 44.38
  • 52 Week Low
  • TEF $3.89
  • NTRA $117.27
  • 52 Week High
  • TEF $5.72
  • NTRA $198.99
  • Technical
  • Relative Strength Index (RSI)
  • TEF 57.63
  • NTRA 65.65
  • Support Level
  • TEF $5.21
  • NTRA $183.88
  • Resistance Level
  • TEF $5.19
  • NTRA $198.99
  • Average True Range (ATR)
  • TEF 0.06
  • NTRA 6.31
  • MACD
  • TEF 0.03
  • NTRA 1.30
  • Stochastic Oscillator
  • TEF 87.18
  • NTRA 69.62

About TEF Telefonica SA

Telefonica operates mobile and fixed networks in Spain (where it is the incumbent operator), the UK, Germany, Brazil, and Latin American countries. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: